Section Arrow
Quote
GANX.NASDAQ
- Gain Therapeutics
Quotes are at least 15-min delayed:2026/01/07 16:04 EST
After Hours
Last
 2.41
0 (0.00%)
Bid
2.4
Ask
2.41
High 2.439 
Low 2.41 
Volume 1.01K 
Regular Hours (Closed)
Last
 2.41
-0.14 (-5.49%)
Day High 
2.71 
Prev. Close
2.55 
1-M High
4.34 
Volume 
1.50M 
Bid
2.4
Ask
2.41
Day Low
2.34 
Open
2.62 
1-M Low
2.14 
Market Cap 
98.08M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 3.08 
20-SMA 3.41 
50-SMA 2.92 
52-W High 4.34 
52-W Low 1.41 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.61/-0.83
Enterprise Value
98.46M
Balance Sheet
Book Value Per Share
0.15
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
0.00
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
ASBPAspire Biopharma Holdings Inc.0.1316+0.0266+25.33%-- 
After Hours 0.1339 +0.0083 +6.61%
ERASErasca5.425+1.795+49.45%-- 
After Hours 4.5193 -0.6507 -12.59%
RXRXRecursion Pharmaceuticals4.885+0.335+7.36%-- 
After Hours 4.84 -0.01 -0.21%
VTYXVentyx Biosciences13.73+3.68+36.62%-- 
After Hours 13.73 0 0.00%
GLUEMonte Rosa Therapeutics23.3816+7.3716+46.04%54.09PE
After Hours 23.28 0 0.00%
Industry overview quotes are at least 15 minutes delayed
Business Description
Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. Geographically, the company operates inSwitzerland, Spain, the United States, and Australia.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.